Meta-Analysis
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2013; 19(34): 5738-5749
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5738
Figure 9
Figure 9 Individual and pooled relative risk (A), Heterogeneity indicators (B) and publication bias indicators (C) for the outcome of “serious adverse events” in the studies considering herbal medicines comparing to placebo therapy in inflammatory bowel disease patients.